Healthcare

Healthcare Stocks: Growth, ROIC & Valuation Analysis

Growth and valuation analysis for 26 healthcare stocks, including Agilent Technologies (A), AbbVie (ABBV), Abbott Laboratories (ABT) and Amgen (AMGN). Each report covers 10 years of book value, earnings per share (EPS), revenue, free cash flow and return on invested capital (ROIC), plus P/E history and analyst price targets. Industries covered: Biotechnology, Drug Manufacturers - General, Medical - Care Facilities, Medical - Devices, Medical - Diagnostics & Research, Medical - Distribution, Medical - Healthcare Plans and Medical - Instruments & Supplies.

TickerCompanyIndustry
A Agilent Technologies, Inc. Medical - Diagnostics & Research
ABBV AbbVie Inc. Drug Manufacturers - General
ABT Abbott Laboratories Medical - Devices
AMGN Amgen Inc. Drug Manufacturers - General
BSX Boston Scientific Corporation Medical - Devices
CI Cigna Corporation Medical - Healthcare Plans
CVS CVS Health Corp. Medical - Healthcare Plans
CYDY CytoDyn Inc. Biotechnology
DHR Danaher Corporation Medical - Diagnostics & Research
EHC Encompass Health Corporation Medical - Care Facilities
ELV Elevance Health Inc. Medical - Healthcare Plans
GILD Gilead Sciences, Inc. Drug Manufacturers - General
ISRG Intuitive Surgical, Inc. Medical - Instruments & Supplies
JNJ Johnson & Johnson Drug Manufacturers - General
LLY Eli Lilly and Company Drug Manufacturers - General
LNAI Lunai Bioworks Inc. Biotechnology
MCK McKesson Corporation Medical - Distribution
MDT Medtronic Plc Medical - Devices
MRK Merck & Co., Inc. Drug Manufacturers - General
MRNA Moderna, Inc. Biotechnology
PFE Pfizer Inc. Drug Manufacturers - General
REGN Regeneron Pharmaceuticals, Inc. Biotechnology
SYK Stryker Corporation Medical - Devices
TMO Thermo Fisher Scientific Inc. Medical - Diagnostics & Research
UNH UnitedHealth Group Incorporated Medical - Healthcare Plans
VRTX Vertex Pharmaceuticals Incorporated Biotechnology

Grade any healthcare stock, not just these

Start your 7-day free trial →

Grades are produced by Ticker INVESTigator's own model from public financial data and are for informational and educational purposes only. They are not investment advice or a recommendation to buy or sell any security. Do your own research.